Health
The state is heading in the right direction, but still has a lot of work to do before it can remove all public health restrictions, such as mask mandates, researchers say.
Researchers have created a platform that can develop effective and highly specific peptide nucleic acid therapies for use against any bacteria within just one week—work could change the way we respond to pandemics and how we approach increasing cases of antibiotic resistance globally.
The current COVID-19 pandemic and other disease outbreaks aren't just biological phenomena, a team of archaeologists argue—these events are also shaped by the broader welfare of human societies.
More than 70% of neurological diseases, including Alzheimer's disease and the concussion-related disorder CTE, are believed to be fueled by protein clusters called tau aggregates. A new study sheds light on how they damage brain cells, and could ultimately lead to new therapies for such "tauopathies."
A study by CU Boulder researchers suggests that thru-hiking, as on the Pacific Crest Trail, might decrease vascular health.
CU Boulder was the first site to roll out a federally-funded study led by the COVID-19 Prevention Network at the Fred Hutchinson Cancer Research Center in Seattle. Study leaders vaccinated 11 of the roughly 700 CU Boulder student volunteers who will ultimately participate.
For nearly one year, a group of scientists and volunteers from across the university has met seven days a week, often sleeping just a few hours a night, to bring students back to campus safely.
CU Boulder researchers have led the way in understanding the COVID-19 pandemic, helping to reveal how the coronavirus spreads through tiny droplets, the importance of flattening “the mental health curveâ€Â and a lot more.
New research finds that only one in five college students who tested positive for COVID-19 while living in residence halls infected their roommates.
As supply increases, so do questions about how the COVID-19 vaccines work and what they do and don’t do. We caught up with Professor Matt McQueen, director of epidemiology, for answers.